Pancreatic ductal adenocarcinoma: The Vision of Heracles
Cancer Cell, cilt.44, sa.9, ss.1721-1726, 2026 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Teknik Not
- Cilt numarası: 44 Sayı: 9
- Basım Tarihi: 2026
- Doi Numarası: 10.1016/j.ccell.2026.07.014
- Dergi Adı: Cancer Cell
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, Chemical Abstracts Core, EMBASE, MEDLINE
- Sayfa Sayıları: ss.1721-1726
- Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet
Özet
Pancreatic ductal adenocarcinoma (PDAC) remains among the deadliest malignancies, as tumors evolve faster than therapies. Resistance is ecological, not merely KRAS driven, involving overlooked players like high-grade pancreatic intraepithelial neoplasias (PanINs), peripancreatic fat, stromal mechanics, myeloid-neural circuits, metabolic rewiring, and systemic host responses. We propose precision interception targeting PanIN/intraductal papillary mucinous neoplasm (IPMN) biology, spatial-functional-proteogenomic classification beyond transcriptomics, the Heracles Protocol (measure, prime, strike, and adapt), and integrated technologies from AI pathology to exosomal delivery and CRISPR-based synergy mapping, together making PDAC more tractable.